Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-037676
Filing Date
2025-04-30
Accepted
2025-04-30 16:41:12
Documents
88
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0239701-10q_abvcbio.htm   iXBRL 10-Q 1289014
2 CERTIFICATION ea023970101ex31-1_abvcbio.htm EX-31.1 8006
3 CERTIFICATION ea023970101ex31-2_abvcbio.htm EX-31.2 8046
4 CERTIFICATION ea023970101ex32-1_abvcbio.htm EX-32.1 3986
5 CERTIFICATION ea023970101ex32-2_abvcbio.htm EX-32.2 4160
  Complete submission text file 0001213900-25-037676.txt   9301055

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20250331.xsd EX-101.SCH 80339
7 XBRL CALCULATION FILE abvc-20250331_cal.xml EX-101.CAL 46841
8 XBRL DEFINITION FILE abvc-20250331_def.xml EX-101.DEF 429303
9 XBRL LABEL FILE abvc-20250331_lab.xml EX-101.LAB 726579
10 XBRL PRESENTATION FILE abvc-20250331_pre.xml EX-101.PRE 455820
91 EXTRACTED XBRL INSTANCE DOCUMENT ea0239701-10q_abvcbio_htm.xml XML 1147458
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 25896173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)